Malachite Innovations (formerly known as Vitality Biopharma) is a company engaged in glycosylated-cannabinoid compounds development and environmental situations investments assessment. It operates through two subsidiaries: Graphium Biosciences and Daedalus Ecosciences. Graphium Biosciences provides glycosylated-cannabinoid treatments for inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. Daedalus Ecosciences specializes in assessing special situation investments, with a particular focus on technological innovations and eco-friendly solutions deployed in economically challenged communities.